Gene Query: SLC22A5

Dataset Description Geneva Score
TNFα Signaling Exposes Latent Estrogen Receptor Binding Sites in Breast Cancer Cells 135.46
TNFα Signaling Exposes Latent Estrogen Receptor Binding Sites in Breast Cancer Cells [GRO-seq] 135.46
Human Long Intergenic Noncoding RNA Linc-ADAL Knockdown in Mature Adipocytes using Lentiviral ShRNA 101.59
Distinct Roles of BET Family Members in ERα Enhancer Function and Gene Regulation in Breast Cancer Cells 85.68
Distinct Roles of BET Family Members in ERα Enhancer Function and Gene Regulation in Breast Cancer Cells [RNA-seq] 85.68
Interphase condensins regulate ligand-depedent enhancer activation (GRO-seq) 64.74
Interphase condensins regulate ligand-depedent enhancer activation 64.74
Functional Importance of eRNAs for Estrogen-dependent Gene Transcriptional Activation 46.5
mRNA expression profile of A549 cells and MSR-A549 cells with or without JQ1 treatment 37.29
A549 cells and MSR-A549 cells 37.29
A non-canonical role of YAP/TEAD is required for activation of estrogen-regulated enhancers in breast cancer [RNA-seq] 34.41
A non-canonical role of YAP/TEAD is required for activation of estrogen-regulated enhancers in breast cancer 34.41
RNA-sequencing of fibrolamellar carcinoma (FLC) cell line treated with miR-375 mimic 31.95
Bromodomain protein BRD4 is required for estrogen receptor-dependent transcription and enhancer activation 29.48
Bromodomain protein BRD4 is required for estrogen receptor-dependent transcription and enhancer activation [RNA-Seq] 29.48
Role of CD133 molecule in WNT response and renal repair 27.04
The RNA-binding profile of Acinus, a peripheral component of the Exon junction complex, reveals its role in splicing regulation 24.25
RNA-seq of MCF10A cells and CAF 20.87
High-Throughput Kinetic Analysis of Fractional Killing 20.47
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype 18.57
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype [RNA-Seq] 18.57
Dtx3L and Androgen Signaling in Prostate Cancer 18.27
BASP1 modifies the Tamoxifen response 18.23
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex (Gro-seq) 17.61
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex 17.61
Clinical and genomic crosstalk between glucocorticoid receptor and estrogen receptor α in endometrial cancer [RNA-seq] 17.52
Clinical and genomic crosstalk between glucocorticoid receptor and estrogen receptor α in endometrial cancer 17.52
EWSR1 influences alternative splicing through direct and indirect mechanisms 17.22
Next Generation Sequencing and m6A sequencing Facilitates Quantitative Analysis of Wild Type and genetic FTO knockdown ccRCC cells Transcriptomes 15.99
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer 15.79
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer (RNA-seq) 15.79
A novel non-canonical signaling pathway mediates TGF-β1-induced glucocorticoid insensitivity in epithelial cells 15.39
IRF1 regulates IFN dependent and independent gene expression 15.3
Transcriptome of EMT induced MCF10A cells by TGFb treatment or SNAIL S6A expression. 14.48
Universal alternative splicing of noncoding exons 14.05
Poly(ADP-ribosyl)ation dependent changes in CTCF-chromatin binding and gene expression in breast cells 13.98
Genome-wide modelling of transcription kinetics reveals patterns of RNA processing delays 13.43
H3K27Ac in MCF7 Y537S ER mutant cells and RNAseq with and without treatment with THZ1 12.5
Estrogen Receptor Beta Impacts Hormone-Induced Alternative mRNA Splicing in Breast Cancer Cells 12.43
RNA sequencing analysis of human podocytes reveals glucocorticoid regulated gene networks targeting non-immune pathways 12.34
Luminal lncRNAs Regulation by ERα-controlled Enhancers in a Ligand-independent Manner in Breast Cancer Cells 11.92
Effects of Belinostat and Dexamethasone treatment of A549 gene expression 11.6
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition 11.48
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition (RNA-seq) 11.48
Gene expression alterations of pancreatic intraepithlial neoplasia 11.4
Patient-iPSC-derived kidney organoids show functional validation of a ciliopathic renal phenotype 11.0
SRSF2 mutations impair hematopoiesis and alter exon recognition 10.92
ZMYND8 reads the dual histone mark H3K4me1-H3K14ac to antagonize the expression of metastasis-linked genes 10.91
ETV4 is necessary for estrogen signaling and growth in endometrial cancer cells [RNA-seq] 10.06
ETV4 is necessary for estrogen signaling and growth in endometrial cancer cells 10.06
Modeling the ESR1 tyrosine 537 mutation with CRISPR-Cas9 for mechanistic studies and evaluation of therapeutic approaches for metastatic breast cancer [RNA-Seq] 9.87
Modeling the ESR1 tyrosine 537 mutation with CRISPR-Cas9 for mechanistic studies and evaluation of therapeutic approaches for metastatic breast cancer 9.87
Effect of estrogen (E2) treatment on the C4-12 relative to the MCF7 cells 9.79
A549 cell transcriptome responses to infection with H7N9 influenza virus 9.68
Exercise-induced transcriptome changes in skeletal muscle adapted to aerobic training 9.68
Oxaliplatin resistance is enhanced by saracatinib via upregulation of ABCG1 and Wnt/β-catenin signaling in hepatocellular carcinoma 9.62
Ribosome profiling and RNA sequencing of MCF10A-ER-Src and fibroblast cell transformation 9.6
A high-throughput screening strategy identifies regulators of alternative splicing via interaction with RNA G-quadruplexes 9.57
Capturing the Interactome of Newly Transcribed RNA (RICK) 9.5
Capturing the Interactome of Newly Transcribed RNA 9.5
Transcriptional profiling of MCF7 cells treated with H3B05942, E2, or standard of care compounds 9.45
Regulation of stem cell property and drug resistance of cancer cells by targeting transcriptional machinery via inhibition of neddylation 8.94
Fixed tissue ChIP-Seq (FiT-Seq) of archived clinical samples reveals chromatin dynamics and tumor-specific enhancer profiles 8.9
Ligand-dependent genomic function of glucocorticoid receptor in triple-negative breast cancer 8.75
HeLa transcriptome induction by IFN gamma and indoleamine 2,3-dioxygenase (IDO) 8.6
MYC interacts with the G9a histone methyltransferase to drive transcriptional repression and tumorigenesis 8.54
Small molecule-mediated reprogramming of human hepatocytes into bipotent progenitor cells 8.53
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression 8.4
NET-CAGE Characterizes the Dynamics and Topology of Human Transcribed Cis-regulatory Elements 8.38
Role of SUMOylation in differential ERα transcriptional repression by SERMs and pure antiestrogens in breast cancer cells 8.33
METTL3 promotes translation in human cancer cells 8.12
Cell-specific expression and function patterns of microRNA-150-5p in liver fibrogenesis 8.03
Understanding the reproducibility and robustness of the kidney organoid differentiation protocol using RNA-seq 7.85
Global analysis of ZNF217 chromatin occupancy in the breast cancer cell genome reveals an association with Eralpha 7.8
LED, a long non-coding RNA activator of enhancer RNAs, is hypermethylated in human cancers 7.76
Changes in human endometrial gland transcriptome over the window of implantation 7.74
The m 6 A-methylase complex recruits TREX and regulates mRNA export. 7.63
Major roles of cyclobutane pyrimidine dimers, nucleotide excision repair and ATR in the alternative splicing response to UV irradiation 7.63
NR2F2 study 7.57
Estrogen response in breast cancer cell line MCF-7 is dependent on NR2F2 [RNA-seq] 7.57
Identification of mesothelial-to-mesenchymal gene signature in ascitic fluid-isolated mesothelial cells through RNA-sequencing 7.53
Elongation Factor TFIIS Prevents Transcription Stress and R-Loop Accumulation to Maintain Genome Stability 7.53
Elongation Factor TFIIS Prevents Transcription Stress and R-Loop Accumulation to Maintain Genome Stability [ RNA-seq] 7.53
Identification of gene signature in ascitic fluid-isolated mesothelial cells from high grade serous ovarian cancer patients 7.48
Loss of ANCO1 repression of AIB1/YAP drives breast cancer progression 7.47
Identification of differentially spliced genes by wild type or S34F mutation of U2AF1 7.44
Polyol pathway links glucose metabolism to the aggressiveness of cancer cells 7.43
PR isoform-specific ER and PR chromatin binding and gene expression observed in-vitro in breast cancer cells. 7.4
The RNA helicase DDX39B regulates IL7R alternative splicing reducing the risk of Multiple Sclerosis 7.36
Epigenome-wide analysis of DNA methylation in lung tissue shows concordance with blood studies and identifies tobacco smoke-inducible enhancers 7.33
Comparative analysis of kidney organoid and adult human kidney single cell and single nucleus transcriptomes 7.31
Different Temporal Effects of Ebola Virus VP35 and VP24 Proteins on Global Gene Expression in Human Dendritic Cells 7.27
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells 7.17
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells [RNA-Seq] 7.17
Pervasive transcription read-through promotes aberrant expression of oncogenes and RNA chimeras in renal carcinoma 7.12
Ribosome profiling of TGFb-treated cells indicates reduced leucine availability 6.87
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition [RNA-Seq] 6.63
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition. 6.63
LNCaP treated with iBET 6.62
Pan-cancer transcriptomic analysis associates long non-coding RNAs with key mutational driver events 6.37
Transcriptome analysis of human reninomas as an approach to understanding juxtaglomerular cell biology 6.32
NRDE2 negatively regulates nuclear exosome functions 6.29
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference [RNA-Seq] 6.22
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference 6.22
Transcriptomic analysis of the HOTAIR-regulated genes 6.15
Differential susceptibility of human pleural and peritoneal mesothelial cells to asbestos exposure 6.14
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations 6.01
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations [RNA-Seq] 6.01
Comparing oestrogen-responsive genes in endometrial and breast cancer cell lines 5.98
Propargite, an environmental chemical, interacts with GWAS identified diabetes genes to impact human pancreatic β-cell death 5.87
Directed differentiation of human embryonic stem cells to corneal endothelial cell-like cells: A transcriptomic analysis 5.82
Splicing and gene expression changes in human mammary epithelial MCF-10A cells expressing SR or SR-like proteins 5.77
Effect of drugs on transcriptomic profiles 5.72
hMTR4 plays a central role in creating balanced nuclear RNA pools for degradation and export 5.68
Tamoxifen Resistance in Breast Cancer is Regulated by the EZH2-ERa-GREB1 Transcriptional Axis 5.63
Defective transcription elongation in a subset of cancers confers immunotherapy resistance (BGI12 RNA-Seq) 5.61
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) II 5.59
Ribosome profiling of A549 cells depleted of RPLP1 and RPLP2 and infected with DENV. 5.58
Proteotranscriptomic profiling of potential E6AP targets in prostate cancer cells 5.57
Transcriptome analysis of AGS cells infected with Helicobacter pylori P12 5.49
Gene expression profile difference among renal location in a stone former 5.48
LINC00520 is Induced by Src, STAT3, and PI3K and Plays a Functional Role in Breast Cancer 5.41
Effect of BRCA1 overexpression on genetic expressions of cervical cancer based on next generation sequencing 5.39
Nutritional control of protein translation 5.32
Strand-specific Dual RNA-seq of Bronchial Epithelial cells Infected with Influenza A/H3N2 Viruses Reveals Splicing of Gene Segment 6 and Novel Host-Virus Interactions 5.32
Acriflavine inhibits the epithelial-to-mesenchymal transition in vitro in liver and pancreatic cancer cells (part of study on HepG2) 5.3
Krüppel-like Transcription Factor-10 (KLF10) Provides a Negative Feedback Mechanism to Suppress TGFβ-Induced Epithelial-to-Mesenchymal Transition 5.21
Krüppel-like Transcription Factor-10 (KLF10) Provides a Negative Feedback Mechanism to Suppress TGFβ-Induced Epithelial-to-Mesenchymal Transition [RNA-Seq] 5.21
Genome wide expression change by RNF168 knocking down in MCF-7 cells 5.18
Hypertonic saline attenuates the cytokine-induced pro-inflammatory signature in primary human lung epithelia 5.17
Tumor hypoxia causes DNA hypermethylation by reducing TET activity (RNA-Seq) 5.11
Tumor hypoxia causes DNA hypermethylation by reducing TET activity 5.11
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 5.11
A pooled single-cell genetic screen identifies regulatory barriers in the continuum of the epithelial-to-mesenchymal transition 5.05
Silencing p300 in MCF7 cells to study expression and alternative splicing 4.98
Epigenome regulation during epidermal lineage commitment [RNA-seq] 4.94
RUNX1 contributes to higher-order chromatin organization and gene regulation in breast cancer cells. 4.94
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 4.91
Transcriptome of human keratinocytes with or without HPV16 oncogene expression 4.88
SETBP1-WT and SETBP1-G870S transcriptional profiles [RNA-Seq] 4.69
SETBP1-WT and SETBP1-G870S epigenetic landscapes 4.69
Genome-wide identification of cancer-specific alternative splicing in circRNA 4.66
Identification of Nrf2 regulated genes by RNA sequencing 4.62
Nrf2 regulated genes in A549 cells 4.62
A comparison of gene expression between lesional and non-lesional derived keratinocytes of Hailey-Hailey disease patients. 4.55
Androgen Receptor-regulated genes in prostate cancer cells 4.47
RNA-seq profiling identifies Androgen Receptor-regulated genes in prostate cancer cells 4.47
Transcriptomes change differerntly in differernt cancer cells upon EPZ-6438 treatment 4.44
Molecular Biomarkers Screened by Next-generation RNA Sequencing for non-sentinel lymph node status predicting in breast cancer patients with metastatic sentinel lymph node 4.42
Downregulation of LATS kinases alters p53 to promote cell migration 4.36
Ascorbate Suppresses VEGF Expression in Retinal Pigment Epithelial Cells 4.32
Histone H3 lysine 4 acetylation-methylation dynamics define breast cancer subtypes [RNA-seq] 4.31
Histone H3 Lysine4 Acetylation-Methylation Dynamics Define Breast Cancer Subtypes 4.31
Molecular Hallmarks of Experimentally Acquired Immunity to Malaria [Pilot Study] 4.31
Waterpipe Smoking Induces Epigenetic Changes in the Small Airway Epithelium 4.31
Waterpipe Smoking Induces Epigenetic Changes in the Small Airway Epithelium [RNA-Seq] 4.31
Effect of Polybrominated diphenyl ethers (PBDEs) on gene expression of MCF7 cells 4.28
RNA-Seq in PWS iPSC-derived neurons 4.22
3D genome of multiple myeloma reveals spatial genome disorganization associated with copy number variations 4.22
Next Generation Sequencing Facilitates Quantitative Analysis of Human Primary and Pluripotent Stem Cell-Derived Epicardial Cell Transcriptomes 4.18
Transcriptome analysis of RANK-positive and RANK-negative luminal progenitor subpopulations in the human breast 4.17
Identification of HOXB13 target genes responsive to BET inhibitors 4.15
Diarrhoeal mechanisms of the Campylobacter jejuni enteritis 4.13
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone 4.13
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone [IMR90_MCF7_RNA-Seq] 4.13
A global identification of PUM1 and PUM2 mRNA targets and their protein cofactors in human seminoma TCam-2 cells 4.11
Contribution of synergism between PHF8 and HER2 signalling to breast cancer development and drug resistance  4.1
Gene expression analysis of the impact of TDP-43 knockout in human cells. 4.09
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion [12Z_RNA-seq] 4.09
FMRP facilitates the nuclear export of N6-methyladenosine-containing mRNAs 4.06
Modulation of Indoleamine 2, 3-dioxygenase 1 Expression by Activated Human T cells in Breast Cancer Cells is Controlled by DNA Promoter Methylation 4.06
α Cell Function and Gene Expression Are Compromised in Type 1 Diabetes 4.04
The pause-initiation limit restricts transcription activation in human cells 4.03
Gene expression analysis of ER+ and ER- breast cancer cell lines with acquired resistance to palbociclib 4.01
Gene expression profiling in lung and breast cancer cells treated by Bloom-specific siRNAs 3.99
Pharmacological Induction of a Progenitor State for the Efficient Expansion of Primary Human Hepatocytes 3.97
Dissection of estrogen receptor alpha signaling pathways in osteoblasts using RNA-sequencing 3.93
Regulartory effect of HNRNPL and LARP on RNA expression in LNCaP prostate cancer cells 3.91
HNRNPL and its RNA Targets in Prostate Cancer 3.91
Over expression of Receptor Activity Modifying Protein 2 in HEK293T cells 3.88
Global transcriptional profiling changes upon knockout of USP22 in human Non-small cell lung cancer cells 3.87
MOF acetyl transferase regulates transcription and respiration in mitochondria 3.87
Recruiting Endogenous ADARs with Antisense Oligonucleotides to Reprogram the Transcriptome 3.84
Estrogen receptor and mTOR signaling rewires cancer metabolism in obesity-associated breast cancer 3.83
Transcriptional profiling of LS1034 cells treated with tepoxalin 3.83
Meta-organization of Translation Centers Revealed by Proximity Mapping of Endoplasmic Reticulum Ribosome Interactors 3.8
Mutation independent activation of the Notch pathway is associated with Lapatinib resistance in Her2+ breast cancer cell lines 3.77
Transcriptome-wide identification of splicing defects upon XAB2 knockdown 3.74
Effects of plasticizers (bisphenol A, bisphenol AF) and an herbicide in MCF7 human breast cancer cells 3.73
ARID1A is a critical regulator of luminal identity and therapeutic response in oestrogen receptor-positive breast cancer (RNA-Seq) 3.72
snRNAs as regulators of alternative splicing 3.7
Pharmacological Induction of a Progenitor State for the Efficient Expansion of Primary Human Hepatocytes 3.69
mRNA cap methyltransferase, RNMT-RAM, promotes RNA pol II transcription 3.66
Research resource: global identification of estrogen receptor β target genes in triple negative breast cancer cells 3.62
Gene expression analysis of human liver progenitor-like cells in culture 3.6
Transcriptome landscape of HeLa response upon triamcinolone acetonide 3.59
ChIP-seq of ER and RUNX2 in MCF7 breast cancer cell lines 3.54
U2AF1 mutations alter splice site recognition in hematological malignancies 3.53
Generation of KRAS signatures using immortalized isogenic lung cells. 3.52
Mitotically associated long non-coding RNA, MANCR regulates cell cycle in triple negative breast cancer cells  3.51
RNA-sequencing analysis of 5' capped RNAs identifies novel differentially expressed genes in sessile serrated colon polyps (SSPs) 3.51
Extracellular matrix (ECM) stiffness and collagen-1 (col-1) responsive genes in 3D cultured mammary epithelial cells 3.5
Browning of human adipocytes requires KLF11 and reprogramming of PPARγ super-enhancers 3.46
UBR7 is a novel E3 ubiquitin ligase for H2BK120 and acts as a tumor-suppressor in breast cancer 3.46
UBR7 is a novel E3 ubiquitin ligase for H2BK120 and acts as a tumor-suppressor in breast cancer [RNA-Seq] 3.46
RNA-seq analysis of control and NRDE2-depleted breast cancer cells 3.43
4sUDRB-seq: measuring transcription elongation and initiation genomewide 3.4
Nuclear Parkin Regulates Transcriptional Response during Hypoxia 3.38
DGCR8 acts as a novel adaptor for the exosome complex to degrade double-stranded structured RNAs 3.37
Diarrhea in lymphocytic colitis: ERK1/2-dependent ENaC dysregulation and claudin-4-, -5- and -8-related barrier defects 3.34
Next Generation Sequencing Facilitates Quantitative Analysis of Human Pluripotent Stem Cell-Derived Endocardial-like And Primary Cardiac Endothelial Cell Transcriptomes 3.34
mitoCPR - a surveillance pathway that protects mitochondria in response to mitochondrial import stress [human] 3.29
mitoCPR - a surveillance pathway that protects mitochondria in response to mitochondrial import stress 3.29
iPSC-Derived Cholangiocytes 3.29
Detection of internal N7-methylguanosine (m7G) RNA modifications by mutational profiling sequencing 3.27
The Unfolded Protein Response Regulator, ATF6, Promotes Mesodermal Differentiation 3.25
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression (nuclear RNA) 3.23
Next Generation Sequencing Analysis of Colorectal Cancer Tissue Transcriptomes 3.18
Global loss of epigenetic and transcriptional fidility defines a subclass of cancer with immunotherapy resistance 3.18
Identification of Atrial Fibrillation associated genes and functional non-coding variants 3.13
Diverse Compounds from Pleuromutilin Lead to a Thioredoxin Inhibitor and Inducer of Ferroptosis 3.1
Paxillin regulates genomic networks in prostate cancer [PC3] 3.01
Next-generation RNA sequencing to determine changes in gene expression during breast cancer progression 3.01
Discovery of cis-spliced chimeric RNAs between adjacent genes in human prostate cells 3.0
Genome-scale identification of transcription factors that mediate an inflammatory network during breast cellular transformation 2.99
RNA-seq during MCF10A-ER-Src cell transformation and upon factor knockdowns 2.99
Global analysis of alternative splicing regulated by RBM10 2.98
MRTF activates TEAD-YAP target gene expression 2.93
G9a-Mediated Methylation of ERα Links the PHF20/MOF Histone Acetyltransferase Complex to Hormonal Gene Expression 2.93
Human co-transcriptional splicing kinetics and coordination revealed by direct nascent RNA sequencing 2.9
RNA-Seq identifies condition-specific biological signatures of ischemia-reperfusion injury in the human kidney 2.87
Improved post thaw function and genetic changes for mesenchymal stromal cells cryopreserved using multicomponent osmolyte solutions 2.86
The RNA hairpin binder TRIM71 modulates alternative splicing by repressing MBNL1 2.84
The RNA hairpin binder TRIM71 modulates alternative splicing by repressing Mbnl1 [RNA-seq & Ribo-seq] 2.84
RNA-Sequencing approach for the identification of novel long non-coding RNA biomarkers in colorectal cancer 2.81
Differentially expressed genes post knock down of lincDUSP26 2.78
Cajal bodies are linked to genome conformation [RNA-Seq] 2.77
Cajal bodies are linked to genome conformation 2.77
Transcription elongation regulates genome 3D structure 2.76
Large-scale epigenetic reprogramming is punctuated late during the evolution of pancreatic cancer progression 2.75
WNK1 kinase and the termination factor PCF11 connect nuclear mRNA export with transcription 2.74
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer 2.74
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer [RNA-seq] 2.74
Next generation sequencing on knockdown of AC093323.3 in lung cancer cells 2.72
Disease modelling of core pre-mRNA splicing factor haploinsufficiency 2.71
Reconstituting development of pancreatic intraepithelial neoplasia from primary human pancreas duct cells 2.71
RNA-seq of HBV-infected Primary Human Hepatocytes treatment by Tazarotene 2.7
Gene expression analysis in response to hypoxic pathway inhibition 2.7
Transcriptome sequencing after MAGOHB knockdown in MAGOH-deleted or non-deleted cancer cells 2.69
Gene expression changes after LOC550643 silencing 2.68
Differential RNA-seq analysis comparing APC-defective and APC-restored SW480 colorectal cancer cells 2.68
Global modulation of signaling pathways by SARM RAD140 in AR/ER+ breast cancer xenografts 2.66
Expression profiles of the four human major ectodermal lineages 2.66
ENCODE Cold Spring Harbor Labs Long RNA-seq 2.64
RNA-seq differential expression studies: more sequence, or more replication? 2.61
Effect of ILF3 depletion in HeLa cells on RNA steady state levels 2.6
Gene expression profile in breast cancer cell lines using RNA sequencing 2.6
An integrative network biology analysis identifies miR-508-3p as the determinant and a prognosis biomarker of the mesenchymal subtype ovarian cancer 2.59
GATA3-mediated chromatin reprogramming in breast cancer cells 2.58
Paxillin regulates genomic networks in prostate cancer [LNCaP] 2.55
The SPOP-containing Complex Functions as an E3 Ligase for SETD2 to Regulate Gene-Specific H3K36me3-Coupled Alternative Splicing 2.55
The RNA-binding protein RBM47 suppresses metastatic breast cancer progression 2.55
ChIPseq and RNAseq analysis of T47D cells with/without silencing TRPS1/CHD4 2.54
U1 snRNP telescripting regulates size-function stratified human genome 2.54
CpG dinucleotides introduced into gag can inhibit HIV-1 gene expression by modulating pre-mRNA splicing 2.51
BioProject PRJNA381064: Convergent origination of a Drosophila-like dosage compensation mechanism in a reptile lineage (Gene expression profiling in several tetrapod species, bulk tissue RNA-seq) 2.5
p38 SAPK and SKIIP induced changes in alternative splicing patterns upon osmostress 2.49
RNA-seq analyisis of PUM2 knockout cells 2.47
Transcriptome analysis of A549 cells expressing a SUMOylation-deficient TRIM28 mutant in the context of influenza A virus infection 2.45
Genomic deletion of malic enzyme 2 confers collateral lethality in pancreas cancer 2.44
Overexpression of NFIB and YBX1 in MCF-7 cells 2.44
RNA sequencing of mechanically strained NHEKs and control NHEKs 2.43
mRNA destabilization is the dominant effect of mammalian microRNAs by the time substantial repression ensues 2.42
mRNA destabilization is the dominant effect of mammalian microRNAs by the time substantial repression ensues (sequencing) 2.42
transcriptomic profiling of HEK293 cells upon individual knockdown of the splicing factors RBM17, U2SURP or CHERP 2.4
Targets of CDK12 on ZR-75-30 breast cancer cells (RNA-seq) 2.4
Biased Expression of the FOXP3Δ3 Isoform in Aggressive Bladder Cancer Mediates Differentiation and Cisplatin Chemotherapy Resistance 2.39
LncRNA expression profiling of ischemic stroke patients 2.36
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer (RNA-seq) 2.35
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer 2.35
Deep sequencing of transcript levels of human embryonic stem cell derived mesothelium (epithelial and mesenchymal forms) and mesothelium from neonatal mouse E15.5 of the heart, lung, liver and gut and ChIP-seq data of the mesenchymal form of mesothelium 2.34
The Polycomb Repressor Complex 1 Drives Double-Negative Prostate Cancer Metastasis by Coordinating Stemness and Immune Suppression 2.32
Transcriptome profiling of hnRNP A2/B1 and A1 depleted cells 2.31
Maturing an Enteric Nervous System in Human Intestinal Organoid-derived Tissue-Engineered Small Intestine 2.31
The mSWI/SNF ATPase module mediates subcomplex identity and non-catalytic targeting in SCCOHT [RNA-seq] 2.31
The ATPase module of mammalian SWI/SNF family complexes mediates subcomplex identity and catalytic activity-independent genomic targeting 2.31
Function of HNRNPC in breast cancer cells by controlling the dsRNA-induced interferon response 2.3
Global gene expression profiles of cardiac progenitors differentiated from human pluripotent stem cells in 3D culture under simulated microgravity 2.3
Sorted MDMs with RFP+GFP+ or RFP+GFP- Mtb 2.29
Transcriptome wide identification of retained introns upon depletion of the splicing factors SNW1 or PRPF8 2.27
Transcriptomic profile of intestinal epithelial cells obtained from ileal endoscopic biopsies from newly-diagnosed, pediatric Crohn's disease patients and healthy controls. 2.27
Effect of circPTPRM on the biological behaviors of hepatocellular carcinoma cells in vitro and its clinical significance. 2.27
Lysine benzoylation is a novel histone mark [RNA-seq] 2.27
Modulation of mitochondrial DNA copy number to induce hepatocytic differentiation of human Amniotic Epithelial cells 2.26
Regulatory network controlling tumor-promoting inflammation in human cancers [RNA-seq] 2.24
Regulatory network controlling tumor-promoting inflammation in human cancers 2.24
High Resolution Mapping of RNA Polymerases Identifies Mechanisms of Sensitivity and Resistance to BET Inhibitors in t(8;21) AML 2.2
Global analysis of pre-mRNA subcellular localization upon splicing inhibition by spliceostatin A 2.18
Role for the Transcriptional Activator ZRF1 in Breast Cancer Progression and Endocrine Resistance 2.14
Differential responses by human respiratory epithelial cell lines to respiratory syncytial virus reflect distinct patterns of infection control 2.1
Co-regulation of splicing by Rbfox1 and hnRNP M [hnRNPM k-d+Rbfox1 RNA-Seq] 2.1
Co-regulation of splicing by Rbfox1 and hnRNP M 2.1
Gene target specificity of the Super Elongation Complex (SEC) family: How HIV-1 Tat employs selected SEC members to activate viral transcription 2.09
AKAP8 inhibits tumor metastasis by antagonizing EMT-associated RNA alternative splicing 2.09
Effects of NSUN2 deficiency on the mRNA 5-methylcytosine modification and gene expression profile in HEK293 cells (RNA-Seq) 2.08
DNA Methylation Reprograms Metabolic Gene Expression in End-Stage Human Heart Failure 2.07
Human iPSC derived glomeruli facilitate accurate modelling of podocytopathy 2.03
Neurofibromin is an Estrogen Receptor alpha Transcriptional Co-repressor in Breast cancer 2.02
SnapShot-Seq: a method for extracting genome-wide, in vivo mRNA dynamics from a single total RNA sample 1.99
ZRANB2 and SYF2 mediated splicing programs converging on ECT2 are involved in breast cancer cell resistance to doxorubicin 1.99
Enhancer Domains in Gastrointestinal Stromal Tumor Regulate KIT Expression and are Targetable by BET Bromodomain Inhibition [RNA-seq] 1.99
Enhancer Domains in Gastrointestinal Stromal Tumor Regulate KIT Expression and are Targetable by BET Bromodomain Inhibition 1.99
FTSEC cells (FT190 and FT194 cell lines) transduced with shRNA to knockdown RNF20 or with control shRNA 1.98
Gene expression profile in FTSEC cells (FT190 and FT194 cell lines) transduced with shRNA to knockdown RNF20 or with control shRNA using RNA-seq. 1.98
Transcriptomic analysis of cultured corneal endothelial cells as a validation for their use in cell-replacement therapy 1.96
PTHrP overexpression in MCF7 cells 1.93
The cohesin complex prevents Myc-induced replication stress 1.88
Obstructed defecation – an enteric neuropathy? An exploratory study of patient samples 1.87
A quantitative chemotherapy genetic interaction map identifies new factors associated with PARP inhibitor resistance 1.86
Mesothelioma xenografts in nude mice: PBS treated versus pirfenidone treated 1.85
Single Cell RNASeq profiling of stromal vascular fraction from Subcutaneous and visceral adipose tissue 1.85
A genomic study of the contribution of DNA methylation to regulatory evolution in primates 1.84
Integrin signaling regulates YAP/TAZ to control skin homeostasis 1.84
Loss of endometrial plasticity in recurrent pregnancy loss 1.84
Loss of endometrial plasticity in recurrent pregnancy loss (RNA-Seq) 1.84
Disease-associated mutation in SRSF2 misregulates splicing by altering RNA binding affinities 1.84
Exploring ILF2 regulatory genes by next-generation sequencing 1.83
Biochemical fractionation of HEK293 nuclei and RNA-seq of chromatin-associated and soluble-nuclear RNA 1.81
TGF-b-activated LncRNA LINC00115 is a critical regulator for glioma stem-like cell tumorigenicity 1.81
A Basal Stem Cell Signature Identifies Aggressive Prostate Cancer Phenotypes 1.8
Derivation of kidney organoids from human pluripotent stem cells [RNA-Seq: Data Set 1] 1.79
CNOT1 and Transcriptomic Landscape of a HeLa Cell Line 1.79
Transcriptome analysis of eosinophilic and noneosinophilic chronic rhinosinusitis with nasal polyps reveals distinct lncRNA expression profiles 1.79
Loss of Nuclear TDP-43 Is Associated with Decondensation of LINE Retrotransposons [RNA-Seq] 1.77
Loss of Nuclear TDP-43 Is Associated with Decondensation of LINE Retrotransposons 1.77
Gene expression analysis of CD4+ and CD4- ILC1 subsets by RNAseq 1.77
hMTR4 plays a central role in creating balanced nuclear RNA pools for degradation and export II 1.76
Genome-wide expression from the esophageal biopsies of subjects with and without eosinophilic esophagitis 1.73
Widespread backtracking by RNA pol II is a major effector of gene activation, 5’ pause release, termination and transcription elongation rate 1.7
Effect of ILF3 on translation during homeostasis and the antiviral response 1.7
Noncoding regions are the main source of targetable tumor-specific antigens 1.68
Identification of ADAR1 adenosine deaminase dependency in a subset of cancer cells 1.66
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. [RNA-Seq] 1.64
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. 1.64
Effect of venetoclax, tedizolid, and combination treatment on gene expression in a venetoclax-resistant AML cell line 1.62
Multiple sclerosis and EAE 1.61
Human optic chiasm from healthy controls and multiple sclerosis patients 1.61
Isolation and sequencing of AGO-bound RNAs reveals characteristics of stem-loop processing in vivo 1.6
Epigenome regulation during epidermal lineage commitment 1.6
Nucleoporin-mediated regulation of cell identity genes 1.6
Bi-allelic Alteration and Dysregulation of the Hippo Pathway in Mucinous Tubular and Spindle Cell Carcinoma of the Kidney 1.57
An improved method for circular RNA purification that efficiently removes linear RNAs containing G-quadruplexes or structured 3’ ends 1.57
Biosynthesis of histone messenger RNA employs a specific 3' end endonuclease 1.54
PTEN interacts with the transcription machinery on chromatin and regulates RNA polymerase II-mediated transcription 1.54
PTEN interacts with the transcription machinery on chromatin and regulates RNA polymerase II-mediated transcription.[RNA-seq and ChIP-seq] 1.54
Dynamics of MBD2 deposition across methylated DNA regions during malignant transformation of human mammary epithelial cells (2) 1.54
Dynamics of MBD2 deposition across methylated DNA regions during malignant transformation of human mammary epithelial cells 1.54
Alternative splicing regulated by QKI and RBFOX1 promotes the mesenchymal cell state in breast cancer 1.52
RNA-sequencing in immortalized human mammary epithelial cells 1.52
Luminal subtype-specific circRNAs in breast cancer cells by a novel tool for external data analysis. 1.51
A Suv39H1-low chromatin state drives migratory cell populations in cervical cancer 1.5
A Suv39H1-low chromatin state drives migratory cell populations in cervical cancer [RNA-Seq] 1.5
Genome wide association study of bone size yields eleven loci that also affect height, bone density, osteoarthritis and fractures 1.49
KDM1A confers invasive and metastatic attributes in lung adenocarcinoma by modulating a non-canonical Integrin ß3-KRAS signaling pathway 1.48
A cell cycle-based functional screen to identify lncRNA-based cancer biomarkers 1.47
Analysis of an artificial zinc finger epigenetic modulator: widespread binding but limited regulation 1.46
Generation of Patient-Matched Malignant and Normal Primary Cell Cultures from Clear Cell Renal Cell Carcinoma Patients 1.44
Critical role for Lymphocytes in Producing FLT3LG in Tumors and Driving Checkpoint Therapy-Receptive Immune Microenvironments 1.44
RNA-sequencing 1.41
Identification of PRMT5-dependent genes in ESA+CD24lowCD44+ MCF7 cells 1.41
RNA Sequencing Analysis of villus tissues from unexplained recurrent spontaneous abortion patients and controls with induced abortions 1.4
Gene expression changes in HSV-1 infected HeLa cells with knockdown of B2M 1.39
GRHL2 is a key lineage determining factor which collaborates with FOXA1 to establish a targetable collateral pathway in the setting of endocrine therapy-resistant breast cancer (RNA-Seq data set 1) 1.38
Profiling of circular RNAs in gastric cancer tissues and adjacent normal tissues 1.37
RNA sequencing data of whole blood cells of normal glucose tolerant (NGT) and gestational diabetes (GDM) pregnant women 1.37
Microvesicle-mediated delivery of miR-1343: impact on markers of fibrosis 1.36
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development [RNA-seq] 1.35
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development 1.35
Modeling Human Cancer-induced Cachexia (Human) 1.33
Messenger RNA expression after silencing or inhibition of MEN1in MCF-7 breast cancer cells 1.33
LEDGF and HDGF2, histone H3K36 methyl-binding proteins that assist RNA polymerase II transcription through nucleosomes 1.31
Multi-omic measurements of heterogeneity in HeLa cells across laboratories 1.3
Overexpression of PHF8 promotes an EMT-related gene signature in MCF10A cells 1.3
Differential Protein Occupancy Profiling of the mRNA Transcriptome 1.23
Gene expression by high-throughput sequencing of T47D-MTVL human breast cancer cells upon H1.4 knock-down and multiple H1 variants 1.22
Trans-chromosomal regulation by a novel lincRNA required for adipogenesis that escapes X-chromosome inactivation 1.18
mRNA sequencing identifies differential gene expresssion profiles between ASCC3 knock-down cells and control cells 1.15
DDX54 regulates transcriptome dynamics during DNA damage response [4SU-seq] 1.14
Kidney compartment specific eQTL studies highlight causal genes and pathways for renal disease development 1.13
Genome-wide Analysis of Chromatin Interactions in Human Cells 1.12
Common inflammatory pathways between NEC and Crohn's disease 1.12
Identification of the O-GlcNAc-regulated alternative splicing events by performing RNA sequencing on HeLa cells with altered O-GlcNAc level. 1.07
Dynamics of Proteo-Transcriptomic Response to HIV-1 Infection 1.07
Intrinsic histone acetyltransferase activity of BRD4 is responsible for nucleosome eviction and transcriptional activation 1.05
Methylome, hydroxymethylome, and integrative transcriptome profiling in human CRC tissue and paired normal tissues 1.05
Identifying transcripts that are transcriptinoally regulated by CBFB and RUNX1 using RNAseq 1.04
Combinatorial Reprogramming of Estrogen Signaling by the Nuclear Receptor Family 3C 1.03
Mutually Exclusive CBC-Containing Complexes Contribute to RNA Fate. 1.02
Identification of expressed and conserved human non-coding RNAs 1.0
Gene expression of collecting duct carcinoma of the kidney 0.97
Specific labeling of stem cell activity in human colorectal organoids using an ASCL2-responsive minigene 0.96
RNA-seq analysis of the human fetal kidney. 0.95
Gene expression analysis of human adenomas. 0.94
ATXN7L3 And ENY2 Coordinate Activity Of Multiple H2B Deubiquitinases Important For Cellular Proliferation And Tumor Growth [RNA-Seq] 0.93
ATXN7L3 And ENY2 Coordinate Activity Of Multiple H2B Deubiquitinases Important For Cellular Proliferation And Tumor Growth 0.93
RNA sequencing of prostate cancer and normal tissue from African Americans and European Americans 0.92
Profiling gene expression changes in primary ovarian tumors compared to matched normal fallopian tubes 0.88
Selective expression of long non-coding RNAs in a breast cancer cell progression model 0.86
Dual RNA-seq – High-resolution comparative Dual RNA-seq time-course 0.86
Dual RNA-seq of diverse human, mouse and pig cell-types infected with various Salmonella strains 0.86
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 0.85
Conservative alteration of chromosomal expression pattern across human solid tumor types 0.84
Transcriptomics profiles of patient-matched normal kidney and ccRCC pairs 0.82
Derivation and differentiation of haploid human embryonic stem cells [RNA-Seq 1] 0.8
The transcriptome of Kawasaki Disease arteritis 0.79
Expression profiles of cultured human epididymis cells reveal the functional diversity of caput, corpus and cauda regions. 0.79
Gene expression profile of human placenta from T. Cruzi infected mothers 0.79
Comprehensive RNA sequencing of healthy human endometrium at two time points of the menstrual cycle 0.78
Derivation and differentiation of haploid human embryonic stem cells 0.76
Generating Patterned Kidney Organoids for Studying Development and Diseases [bulk RNA-Seq] 0.74
Profiles of ribosome-associated mRNAs regulated by expression of wild-type (WT) or R534H variant of DDX3 with or without Sodium Arsenite treatment 0.73
Total RNA profiles associated with DDX3 wild-type (WT) or R534H variant expression with or without sodium arsenite treatment [RNA-seq] 0.73
Deep RNA sequencing of the human placental transcriptome 0.71
Rnase L reprograms translation by widespread mRNA turnover escaped by antiviral mRNAs 0.7
A novel transcriptional network for the Androgen Receptor in human epididymis epithelial cells [RNA-Seq] 0.7
A novel transcriptional network for the Androgen Receptor in human epididymis epithelial cells 0.7
Unlocking the transcriptomic potential of formalin-fixed paraffin embedded clinical tissues: Comparison of gene expression profiling approaches 0.7
Unlocking the transcriptomic potential of formalin-fixed paraffin embedded clinical tissues: Comparison of gene expression profiling approaches [RNA-Seq] 0.7
SMUG1 promotes telomere maintenance through telomerase RNA end-processing 0.69
mRNA recovered upon RNF219 IP. [RNA-IP] 0.69
Group A Streptococcus M1T1 Intracellular Infection of Primary Tonsil Epithelial Cells Dampens Levels of Secreted IL-8 Through the Action of SpyCEP 0.68
Divergent expression and metabolic functions of human glucuronosyltransferases through alternative splicing 0.68
Human Pancreatic Islets Expressing HNF1A Variant Have Defective β cell Transcriptional Regulatory Networks 0.68
Genome wide impact of loss of mechanoluminal stimulation on neonatal intestine 0.65
Next generation sequencing of the transcriptome in MCF-7 cells with/without SRA knockdown 0.65
MicroRNA-125a-5p overexpression in human macrophages 0.64
Genomic Reorganization of Lamin-Associated Domains in Cardiac Myocytes is Associated with Differential Gene Expression and DNA Methylation in Human Dilated Cardiomyopathy [RNA-Seq] 0.64
Genomic Reorganization of Lamin-Associated Domains in Cardiac Myocytes is Associated with Differential Gene Expression and DNA Methylation in Human Dilated Cardiomyopathy 0.64
CDK12 regulates alternative last exon mRNA splicing and promotes invasion of a breast cancer cell line 0.6
Azithromycin induces epidermal differentiation and multivesicular bodies in airway epithelia 0.57
Gene expression for surgically treated pancreatic cancer after one neoadjuvant vaccine dose 0.56
Epigenetic reprogramming at estrogen-receptor binding sites alters the 3D chromatin landscape in endocrine resistant breast cancer [RNA-seq] 0.54
Epigenetic reprogramming at estrogen-receptor binding sites alters 3D chromatin landscape in endocrine resistant breast cancer 0.54
RNA-sequencing of pediatric idiopathic dilated cardiomyopathy patients and healthy controls 0.52
Genes altered in expression by Cisplatin treatment in lung cancer cell lines 0.51
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor Alpha Bound Enhancers 0.51
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor Alpha Bound Enhancers [RNA-Seq] 0.51
Transcriptional changes in lymphoma cells induced by LSD1 depletion 0.5
Histone demethylase LSD1 is required for germinal center formation and BCL6 driven lymphomagenesis 0.5
Transcriptomic profiling of sequential tumours from breast cancer patients provides a global view of metastatic expression changes following endocrine therapy 0.49
Assessing placental maturity through histological and transcriptomic analyses in idiopathic spontaneous preterm birth 0.49
The impact of oil spill to lung health – insights from an RNA-seq study of human airway epithelial cells 0.48
Molecular analysis of renal cell carcinoma with unclassfied histology 0.48
Molecular analysis of renal cell carcinoma with unclassfied histology [gene expression] 0.48
Sex differences in transcriptomic profiles in aged kidney cells of renin lineage 0.48
Defective transcription elongation in a subset of cancers confers immunotherapy resistance 0.47
Transposon-based construction of strand-specific RNA-seq libraries 0.47
eRNA: A graphic user interface-based tool for RNA sequencing data analysis [mRNA-Seq] 0.46
eRNA: A graphic user interface-based tool for RNA sequencing data analysis 0.46
Sex-specific gene expression differences are evident in human embryonic stem cells and during in vitro differentiation of human placental progenitor cells 0.46
RNA-Seq and expression data from human adipose tissue 0.43
Tissue-specific RNA-seq in human evoked inflammation identifies novel blood and adipose lincRNA signatures of cardio-metabolic diseases 0.43
p63 establishes epithelial enhancers de novo at critical craniofacial development genes 0.41
Expression profiling of converted and control dermal BJ fibroblasts 0.41
Transcriptome profiling of omental adipose tissues in human obesity by RNA-Seq 0.41
Gene expression analysis upon mtDNA depletion 0.4
Gene expression analysis upon mtDNA depletion [RNA-seq] 0.4
Illumina Human Polycystic Liver Disease and Normal Biliary Stem Cell RNAseq 0.38
Defective transcription elongation in a subset of cancers confers immunotherapy resistance (human cell lines RNA-Seq) 0.37
Genome-wide RNA-sequencing (RNA-seq) of benign and malignant prostate cell lines without and with androgen (R1881) stimulation. 0.34
Interaction between mitoNEET and NAF-1 in cancer cells 0.34
Quantitative profiling of the UGT transcriptome in human drug metabolizing tissues [Total RNA] 0.34
The MEF2B Regulatory Network - RNA-seq data 0.31
The MEF2B Regulatory Network 0.31
Interleukin-1β induces mitochondrial DAMP production to activate STING-dependent innate immune programs 0.3
MiR-26 dampens IL-6 production by down-regulating TNF-a/NF-kB signaling through silencing HMGA1 and MALT1 and not by directly targeting IL-6 mRNA 0.28
A SRp55-regulated alternative splicing network controls pancreatic beta cell survival and function 0.27
SREBP1 drives Keratin 80-dependent cytoskeletal changes and invasive behavior in endocrine resistant ERα breast cancer 0.26
Modulation of gene transcription and epigenetics of colon carcinoma cells by bacterial membrane vesicles 0.24
A systematic analysis of the time series gene expression in TGF-beta induced EMT by Next-generation sequencing 0.21
TALEN-based knockout of mir-141 and mir-200c in SK-BR-3 cells 0.21
Functional genomic analysis of the haploinsufficient tumor suppressor, CUX1 0.2
Transcriptome-wide modulation of splicing by the exon junction complex 0.18
Estrogen-independent molecular actions of mutant estrogen receptor alpha in endometrial cancer [RNA-seq] 0.17
Estrogen-independent molecular actions of mutant estrogen receptor alpha in endometrial cancer 0.17
Recovery and analysis of nascent RNA 0.17
The oncogenic BRD4-NUT chromatin regulator drives aberrant transcription within large topological domains 0.17
Age-Related Gene Expression Changes in Prostate Cancer Patients 0.16
Age-Related Gene Expression Changes in Prostate Cancer Patients [RNA-Seq] 0.16
Polycomb complexes associate with enhancers to promote oncogenic transcriptional programs in cancer 0.14
rG4-seq reveals widespread formation of G-quadruplex structures in the human transcriptome 0.13
Suppression of NAF-1 in Breast Cancer Cells Reduces their Tumorigenicity by Interfering with Cellular Iron Distribution and Metabolism and Ensuing ROS Formation and Apoptosis 0.11
Aberrant expression profile of lncRNA and mRNA in dilated cardiomyopathy by RNA-sequence 0.1
Transcriptomic analysis of the role of the integrin a6b4 in detached cells 0.07
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates 0.05
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates [RNA-seq] 0.05
Recurrent somatic mutations in POLR2A define a distinct subset of meningiomas [RNA-seq] 0.05
Recurrent somatic mutations in POLR2A define a distinct subset of meningiomas 0.05
RNA sequencing of prostate cancers reveal insights on the prognostic significance of visibility on multi-parametric MRI 0.0
Human Adult Sorted Live Cell Erythroblasts RNA-Seq. 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation